AXCELIS ANNOUNCES SUCCESSFUL QUALIFICATION OF PURION XEmax FOR PRODUCTION

Rhea-AI Summary

Axcelis Technologies, Inc. (NASDAQ: ACLS) announced the qualification of its Purion XEmax high energy ion implant system for production at a leading CMOS image sensor manufacturer. This advancement is expected to enhance image sensor technology and production capabilities, driving growth in the image sensor market. The Purion XEmax is designed for high-performance applications, featuring advanced filtration systems to maintain photodiode quality. This move reflects Axcelis’ commitment to innovation in semiconductor solutions amid increasing demand.

Positive

• Successful qualification of the Purion XEmax system, expanding its footprint in the image sensor market.
• Enhanced manufacturing capabilities for next-generation image sensors, expected to drive revenue growth.
• Strong market demand for image sensor technology supports future growth opportunities.

Negative

• None.

New Product Line Extension Features Enabling Technology for Image Sensor Market

BEVERLY, Mass., Oct. 10, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of innovative, high-productivity solutions for the semiconductor industry, announced today the successful qualification of a Purion XEmax™ high energy ion implant system for production at a leading CMOS image sensor manufacturer.

President and CEO Mary Puma commented, "We're pleased to have enhanced this customer's next generation image sensor technology development and manufacturing capabilities. We are excited that growth in the image sensor market, combined with Purion XEmax systems at multiple customer sites, will further expand this tool's footprint and fuel Purion Platform growth."

The Purion XEmax:

The new Purion XEmax high energy implanter was designed for emerging, high performance image sensor applications. The enhanced beamline features multiple filtration systems to eliminate energetic metal contaminants which can otherwise result in compromised dark current and white pixel count levels. The system is built on the industry leading Purion XE high energy implant platform and features Axcelis' patented Boost Technology™, which delivers beam energies up to 15 MeV. With innovative technology, the Purion XEmax is delivering the tightest angle and overall process control to enable higher quality photodiode performance for next generation devices.

About Axcelis:

Axcelis (NASDAQ: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-successful-qualification-of-purion-xemax-for-production-301644226.html

SOURCE Axcelis Technologies, Inc.

FAQ

What is the significance of Axcelis' Purion XEmax announcement on October 10, 2022?

The announcement signifies the successful qualification of the Purion XEmax ion implant system for production at a major CMOS image sensor manufacturer, enhancing technology capabilities in the sector.

How does the Purion XEmax impact the image sensor market?

The Purion XEmax is designed to improve production capabilities and quality in the image sensor market, which is experiencing growth.

What technology does the Purion XEmax utilize?

The Purion XEmax employs advanced filtration systems and Axcelis' patented Boost Technology to enhance performance in high-energy ion implantation.